Photodynamic therapy of Ehrlich carcinoma in mice with liposomal boronated chlorin e6

«Radiation and Risk», 2020, vol. 29, No. 3, pp.42-51

DOI: 10.21870/0131-3878-2020-29-3-42-51


Abramova O.B. – Head Lab., C. Sc., Med. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: 8 (910) 510-08-62; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Drozhzhina V.V. – Researcher
Churikova T.P. – Researcher Assistant
Beregovskaya E.A. – Research Assistant
Kaplan M.A. – Head of Dep., MD, Prof.
Ivanov S.A. – Director, MD, Prof. A. Tsyb MRRC.
Kaprin A.D. – General Director, Academician of RAS, MD, Prof. NMRRC.

A. Tsyb MRRC, Obninsk
1 NMRRC Russian Ministry of Health, Moscow


This paper reports results of estimating effectiveness of the liposomal boronated chlorin e6 photosensitizer for photodynamic therapy. For the study Ehrilich carcinoma-bearing mice were used as a model. Pharmacokinetics of the photosensitizer, its accumulation in tumor and other organs and tissues was studied to determine the optimal time interval between chlorin e6 administration and laser irradiation. Effectiveness of the treatment was evaluated by the following parameters: completeness of tumor regression (%); tumor absolute growth rate in mice with the continued tumor growth; life expectancy increase (%) in tumor-bearing mice compared to the control animals; evidence of tumor recurrence during 90 days after the treatment. The study revealed high antitumor effect of photodynamic therapy with liposomal boronated chlorin e6 photosensitizer on Ehrlich carcinoma in mice. The treatment performed within the optimal time interval between the photosensitizer administration and PDT produces the highest inhibiting effect on tumor.

Key words
photodynamic therapy, Ehrlich carcinoma, photosensitizer, accumulation dynamics, contrast index, laser, tumor growth inhibition, complete tumor regression, increase in life expectancy, treatment.


1. Filonenko E.V., Serova L.G. Photodynamic therapy in clinical practice. Biomedical Photonics, 2016, vol. 5, no 2, pp. 26-37. (In Russian).

2. Filonenko E.V. Fluorescent diagnostics and photodynamic therapy – justification of application and possibilities in oncology. Fotodinamicheskaya terapiya i fotodiagnostika – Photodynamic Therapy and Photodiagnostics, 2014, vol. 3, no. 1, pp. 3-7. (In Russian).

3. Stranadko E.F. The main stages of development and the current state of PDT in Russia. Biomedical photonics, 2014, vol. 3, no. 1, pp. 3-7. (In Russian).

4. Abakushina E.V., Romanko Yu.S., Kaplan M.A., Kaprin A.D. Antitumor immune response and photodynamic therapy. Radiaciya i risk – Radiation and Risk, 2014, vol. 23, no. 4, pp. 92-98. (In Russian).

5. Lukyanets E.A. Search for new photosensitizers for photodynamic therapy. Fotodinamicheskaya terapiya i fotodiagnostika – Photodynamic Therapy and Photodiagnostics, 2013, vol. 2, no. 3, pp. 3-16. (In Russian).

6. Zhang J., Jiang C., Figueiró Longo J.P., Azevedo R.B., Zhang H., Muehlmann L.A. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm. Sin. B, 2018, vol. 8, no. 2, pp. 137-146.

7. Asano R., Nagami A., Fukumoto Y., Miura K., Yazama F., Ito H., Sakata I., Tai A. Synthesis and biological evaluation of new boroncontaining chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer. Bioorg. Med. Chem. Lett., 2014, vol. 24, no. 5, pp. 1339-1343.

8. Nikitina R.G., Kaplan M.A., Olshevskaya V.A., Rodina J.S., Drozhzhina V.V., Morozova T.G. Photodynamic therapy with boronated chlorin as a photosensitizer. J. Cancer Sci. Ther., 2011, vol. 9, no. 3, pp. 216-219.

9. Raikov A.O., Hashem A., Baryshnikova M.A. Liposomes for the targeted delivery of antitumor drugs. Rossijskij bioterapevticheskij zhurnal – Russian Journal of Biotherapy, 2016, vol. 15, no. 2, pp. 90-96. (In Russian).

10. Weijer R., Broekgaarden M., Kos M., Van Vught R., Rauws A.J., Breukink E., Van Gulik T.M., Storm G., Heger M. Enhancing photodynamic therapy of refractory solid cancers: Combining second-generation photosensitizers with multi-targeted liposomal delivery. J. Photochem. Photobiol. C: Photochem. Rev., 2015, vol. 23, pp. 103-131.

11. Dmitrieva M.V., Oborotova N.A., Orlova O.L., Polozkova A.P., Agapov I.I., Kirpichnikov M.P. Liposomal dosage form of borchlorin. Rossijskij bioterapevticheskij zhurnal – Russian Biotherapeutic Journal, 2014, vol. 13, no. 1, pp. 31-36. (In Russian).

12. Machinskaya EA, Ivanova-Radkevich V.I. A review of the mechanisms of selective accumulation of photosensitizers of various chemical structures in tumor tissue. Fotodinamicheskaya terapiya i fotodiagnostika – Photodynamic Therapy and Photodiagnostics, 2013, vol. 2, no. 4, pp. 28-32. (In Russian).

13. Kruglyakova A.A. Features of the pharmacokinetics of liposomal drugs. Razrabotka i registraciya lekarstvennyh sredstv – Development and Registration of Medicines, 2012, no. 1, pp. 37-40. (In Russian).

14. Loshchenov V.B., Linkov K.G., Savelyeva T.A., Loshchenov M.V., Model S.S., Borodkin A.V. Hardware and instrumentation of fluorescence diagnostics and PDT. Fotodinamicheskaya terapiya i fotodiagnostika – Photodynamic Therapy and Photodiagnostics, 2013, vol. 4, no. 3, pp. 17-25. (In Russian).

15. Burmistrova N.V., Drozhzhina V.V., Kaplan M.A., Yuzhakov V.V., Bandurko L.N., Tsyganova M.G., Ivanov S.A., Arkhipova L.M., Abramova O.B. Study of efficiency of photodynamic therapy of Earlich carcinoma micewith intravenous introduction of photosensibilizer of liposomal boronated chlorin e6. Radiaciya i risk – Radiation and Risk, 2019, vol. 28, no. 4, pp. 96-107. (In Russian).

16. Guidelines for preclinical studies of drugs. Part 1. Moscow, Grif and K, 2012, pp. 640-670. (In Russian).

Full-text article (in Russian)